3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thromboembolism
1
Neoplasms
1
Embolism
1
Interventions
Cyclophosphamide
24
fludarabine phosphate
18
Whole-Body Irradiation
17
fludarabine
16
Mycophenolic Acid
16
Tacrolimus
12
Peripheral Blood Stem Cell Transplantation
12
Busulfan
12
Melphalan
11
apixaban
10
Biopsy
7
Rivaroxaban
6
Granulocyte Colony-Stimulating Factor
6
Specimen Handling
5
Filgrastim
5
Cyclosporine
5
Azacitidine
5
thymoglobulin
4
X-Rays
4
Sirolimus
4
Rituximab
4
Injections
4
Enoxaparin
4
Decitabine
4
Bone Marrow Transplantation
4
Aspirin
4
Antilymphocyte Serum
4
venetoclax
3
pegylated granulocyte colony-stimulating factor
3
hetrombopag
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Dabigatran
×
Classical hematology
×
1 year
×
Clear all
NCT04618913
2026-05-26
VICTORIE
Pfizer
Active not recruiting
1 enrolled